Comparison of Eligibility Criteria and Baseline Characteristics Between the Patient Populations of evoke and evoke+, Clarity AD and TRAILBLAZER-ALZ-2
Authors:
Paul Mystkowski1; Howard H. Feldman2; Philip Scheltens3; Oskar Hansson4,5; Mary Sano6,7; Wiesje M. van der Flier8; Lars Bardtrum9; Peter Johannsen9; Rose Jeppesen9; Teresa León9; Charlotte T. Hansen9; Jeffrey Cummings10